The Impact of a Brief Motivational Intervention on Unprotected Sex and Sex While High Among Drug-Positive Emergency Department Patients Who Receive STI/HIV VC/T and Drug Treatment Referral as Standard of Care
First Online: 20 January 2012 DOI:
10.1007/s10461-012-0134-0 Cite this article as: Bernstein, E., Ashong, D., Heeren, T. et al. AIDS Behav (2012) 16: 1203. doi:10.1007/s10461-012-0134-0 Abstract
This randomized, controlled trial, conducted among out-of-treatment heroin/cocaine users at an emergency department visit, tests the impact on sexual risk of adding brief motivational intervention (B-MI) to point-of-service testing, counseling and drug treatment referral. 1,030 enrollees aged 18–54 received either voluntary counseling/testing (VC/T) with drug treatment referral, or VC/T, referral, and B-MI, delivered by an outreach worker. We measured number and proportion of non-protected sex acts (last 30 days) at 6 and 12 months (
n = 802). At baseline, 70% of past-30-days sex acts were non-protected; 35% of sex acts occurred while high; 64% of sexual acts involved main, 24% casual and 12% transactional sex partners; 1.7% tested positive for an STI, and 8.8% for HIV. At six or 12 month follow-up, 20 enrollees tested positive for Chlamydia and/or Gonorrhea, and 6 enrollees HIV sero-converted. Self-reported high-risk behaviors declined in both groups with no significant between-group differences in behaviors or STI/HIV incidence. Keywords HIV Emergency department Brief motivational intervention Sexual behavior risk Electronic supplementary material
The online version of this article (doi:
) contains supplementary material, which is available to authorized users. 10.1007/s10461-012-0134-0 References
Jarlais DCD, Semaan S. HIV prevention and psychoactive drug use a research agenda. J Epidemiol Community Health. 2009;63:191–6.
Copenhaver MM, Johnson BT, Lee IC, Harman JJ, SHARP Research Team. Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy. J Subst Abuse Treat. 2006;31(2):163–71.
Wechsberg WM, Lam WK, Zule WA, Bobashev G. Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers. Am J Public Health. 2004;94(7):1165–73.
Sterk CE, Theall KP, Elifson KW. Effectiveness of a risk reduction intervention among African American women who use crack cocaine. AIDS Educ Prev. 2003;15(1):15–32.
Meader N, Li R, Des Jarlais DC, Pillings S. Psychosocial intervention for reducing injection and sexual risk behavior for preventing HIV in drug users. The Cochrane Database of Systematic Reviews. 2010; Issue 1. art. No. CD007192. doi:
Madras BK, Compton WM, Avula D, Stegbauer T, Stein JB, Clark WH. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug Alc Depend. 2009;99:280–95.
Vasilaki EI, Hosier SG, Cox WM. The efficacy of motivational interviewing as a brief intervention for excessive drinking: a meta-analytic review. Alcohol Alcohol. 2006;41(3):328–35.
Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction. 2001;96:1725–42.
West DS, DiLillo V, Bursac Z, Gore SA, Greene PG. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care. 2007;30:1081–7.
Cooperman NA, Arnsten JH. Motivational interviewing for improving adherence to antiretroviral medications. Curr HIV/AIDS Rep. 2005;2(4):159–64.
Greaves CJ, Middlebrooke A, O’Loughlin L, Holland S, et al. Motivational interviewing for modifying diabetic risk: a randomized control trial. Br J Gen Pract. 2008; 535–40.
Bernstein J, Bernstein E, Tassiopoulos K, Heeren T, Levenson S, Hingson R. Brief motivational intervention at a clinic visit reduces cocaine and heroin use. Drug Alc Depend. 2005;77:49–59.
Bernstein E, Bernstein J, Levenson S. Project ASSERT: an ED based intervention to increase access to primary care, preventive services, and the substance abuse treatment system. Ann Emerg Med. 1997;30:181–9.
Bernstein E, Edwards E, Bliss C, Heeren T, Bernstein J. Screening and brief intervention to reduce Marijuana use among youth and young adults in a pediatric emergency department. Acad Emerg Med. 2009;16:1174–85.
Skinner HA. The drug abuse screening test (DAST-10): guidelines for administration and scoring. Toronto: Addiction Research Foundation; 1995.
Ruggiero KJ, DelBen K, Scotti JR, Rabalais AF. Psychometric properties of the PTSD Checklist-Civilian version. J Traum Stress. 2003;16:495–502.
Sobell LC, Sobell MB. Timeline followback user’s guide: a calendar method for assessing alcohol and drug use. Toronto: Addiction Research Foundation; 1996.
Midanik LT, Hines AM, Barrett DC, Paul JP, Crosby GM, Stall RD. Self-reports of alcohol use, drug use and sexual behavior: expanding the timeline follow-back technique. J Stud Alcohol. 1998;59:681–9.
Carey MP, Carey KB, Maisto SA, Gordon CM, Weinhardt LS. Assessing sexual risk behavior with the Timeline Followback (TLFB) approach: continued development and psychometric evaluation with psychiatric outpatients. Int J STD AIDS. 2001;12(6):365–75.
Miller WR. Enhancing motivation for change in substance abuse treatment: treatment improvement protocol (TIP) series DHHS: publication no 99–3354. Rockville: Department of Health and Human Services; 1999.
Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. 2nd ed. New York: Guilford Press; 2002.
Bandura A. Self-efficacy: toward a unifying theory of behavior change. Psychol Rev. 1977;84:191–215.
Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol. 1983;51:390–5.
Velicer WF, DiClemente CC, Prochaska JO, Brandenberg N. A decisional balance measure for assessing and predicting smoking status. J Pers Soc Psychol. 1985;48:1279–89.
Zuniga R, Cartier J, Anglin MD, Danila B, Ryan R, Mantius K. Staying in touch: a fieldwork manual of tracking procedures for locating substance abusers in follow-up studies. 2nd ed. Los Angeles: UCLA Integrated Substance Abuse Programs; 2003.
Woolard RH, Carty K, Wirtz P, et al. Research fundamentals: follow-up of subjects in clinical trials: addressing subject attrition. Acad Emerg Med. 2004;11:859–66.
Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(RR-14):1–17.
Semaan S, Jarlais DCD, Malow R. Behavior change and health-related interventions for heterosexual risk reduction among drug users. Subst Use Misuse. 2006;41(10–12):1349–78.
Semaan S, Jarlais DCD, Sokolow E, et al. A Meta-analysis of the Effect of HIV prevention interventions on the sex behaviors of drug users in the United States. J Acquir Imm Defic Synd. 2002;30:S73–93.
Calsyn DA, Crits-Christoph P, Hatch-Maillette MA, Doyle SR, Song YS, Coyer S, Pelta S. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction. 2010;105(1):100–8.
Bernstein J, Bernstein E, Heeren TC, Bernstein E. Mechanisms of change in control group drinking in clinical trials of brief alcohol intervention: implications for bias toward the null. Drug Alcohol Rev. 2010;29(5):498–507.
Sterk CE, Elifson KW, Theall KP. Individual action and community context: the health intervention project. Am J Prev Med. 2007;32(6S):S177–81.
Liebshutz JM, Finley EP, Braslin PG, Christiansen D, Horton NJ, Samet JH. Screening for sexually transmitted infections in substance abuse treatment programs. Drug Alc Depend. 2003;70:93–9.
CrossRef Copyright information
© Springer Science+Business Media, LLC 2012